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Summary
 
To evaluate the role of natural immunoglobulin (Ig)M in the immediate response against mi-
crobial infection, we tested mutant mice that are deficient in secreted (s)IgM in an acute peri-
tonitis model induced by cecal ligation and puncture (CLP). 20% of wild-type mice died
within 32 h of CLP, whereas 70% of sIgM-deficient mice died within the same time period.
The increased susceptibility was associated with a reduced level of tumor necrosis factor
(TNF)-
 
a
 
, a decreased neutrophil recruitment and an increased bacterial load in the perito-
neum, and elevated levels of endotoxin and proinflammatory cytokines in the circulation. Re-
sistance to CLP by sIgM-deficient mice was restored by reconstitution with polyclonal IgM
from normal mouse serum. Reconstitution with a monoclonal IgM specific to phosphatidyl-
choline, a conserved cell membrane component, has a modest effect but a monoclonal IgM
specific to phosphocholine is not protective. These findings demonstrate a critical role of natu-
ral IgM in the immediate defense against severe bacterial infection.
Key words: natural antibody • immunoglobulin M • complement • bacterial infection • 
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T
 
he spontaneously occurring immunoglobulins in hu-
man cord blood, in “antigen-free” mice, and in nor-
mal individuals in the absence of apparent antigen stimula-
tion are referred to as natural antibodies (for reviews, see
references 1–3). Most of these antibodies are of IgM class
produced by B-1 cells. B-1 cells differ from conventional B
cells in that they are generated predominantly during fetal
and neonatal development (4–6). Because of the preferen-
tial usage of J
 
H
 
-proximal V
 
H
 
 gene segments and the lack of
terminal deoxynucleotidyl transferase activity in precursor
B cells during early ontogeny (7–9), the repertoire of natu-
ral antibodies is much more restricted than those produced
by conventional B cells. A large proportion of the natural
antibodies are polyreactive to phylogenetically conserved
structures such as nucleic acids, heat shock proteins, carbo-
hydrates, and phospholipids (4–6, 10). For example, 5–15%
of murine B-1 cells express IgM specific to phosphatidyl-
choline (PtC), a common membrane component exposed
after treatment of red blood cells with proteolytic enzyme
bromelain (11, 12).
The physiologic functions of natural antibodies have
long been a subject of interest. Among many postulated
functions, natural IgM, together with factors of the innate
immunity, is thought to provide a first line of defense
against microbial infection (1–3). In addition to its natural
presence, IgM is a pentamer and could potentially bind to
10 antigenic determinants per molecule. The polyreactivi-
ties enable it to react with a broad spectrum of antigens si-
multaneously. Furthermore, IgM is a potent complement
activator. Activation of complement can directly result in
the lysis of invading bacteria or opsonization of infectious
particles for efficient phagocytosis by macrophages and
polymorphonuclear leukocytes. However, due to the lack
of suitable animal models, the putative function of natural
IgM has not been critically examined under physiological
conditions.
We have previously constructed a mutant mouse strain
in which B cells are specifically deficient in secreted (s)IgM
but still express membrane-bound IgM and secrete other Ig
isotypes (13). To determine the physiological role of natu-
ral IgM in bacterial infection, we examined the susceptibil-
ity of sIgM-deficient mice in an acute septic peritonitis
model induced by cecal ligation and puncture (CLP [14]).
We show that sIgM-deficient mice are much more suscep-
tible than wild-type mice as indicated by an inability to
clear bacteria from peritoneum, a systemic release of proin-
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flammatory cytokines, and a high mortality rate. Resistance
to CLP by sIgM-deficient mice was restored by reconstitu-
tion with polyclonal IgM from normal mouse serum and to
a less extent by monoclonal IgM specific to PtC but not to
phosphocholine (PC). Our findings demonstrate a critical
role of natural IgM in the immediate response against acute
systemic bacterial infection.
 
Materials and Methods
 
Mice.
 
Mice deficient in sIgM were described previously (13).
Mutant mice either in the mixed C57BL/6 
 
3 
 
129 background or
pure 129 background were maintained in specific pathogen–free
facilities and used at 6–8 wk of age. Studies were performed ac-
cording to institutional guidelines for animal use and care.
 
CLP.
 
The surgical procedure was performed as described
(15). In brief, mice were anesthetized by avertin (0.2 ml of 2.5%
solution per 10 g body wt), and a 0.5-cm midline incision was
made in the peritoneum. The distal two thirds of the cecum was
ligated with a silk suture, and the cecum was punctured once
with an 18.5-gauge needle, and then gently squeezed to ensure
that the holes were completely open. The cecum was returned to
the peritoneal cavity, and the body wall was stitched and the inci-
sion was closed with 9-mm stainless steel wound clips. Sham con-
trols were operated on in the same manner but without ligation
and puncture. In some experiments, mice were killed 3 h after
CLP. Peritoneal lavage was harvested after injection of 3 ml of
PBS with 2% FCS and used for further assays (see below). In
other experiments, mice were bled through the tail vein at 1.5, 3,
6, and 12 h after CLP and sera were used for further assays. Statis-
tical analysis for survival was performed using the Stata program
(Stata Corp., College Station, TX).
 
IgM Purification.
 
Polyclonal IgM was isolated from normal
mouse serum (Sigma Chemical Co., St. Louis, MO) using an
anti-IgM affinity column. Sera were precipitated by ammonium
sulfate (50% saturation), and the precipitate was dissolved in PBS
and dialyzed. Recovered solution was filtered through a 0.45-
 
m
 
m
filter and applied to a 5-ml protein G–sepharose column (Sigma
Chemical Co.) to remove IgG. The flow-through was reconsti-
tuted with NaCl to a final concentration of 0.5 M and applied to
a 4-ml anti-IgM sepharose column (Zymed Laboratories, Inc.,
South San Francisco, CA). Bound protein was eluted with 0.1 M
glycine/0.15 M NaCl, pH 2.5, and neutralized with 1 M Tris,
pH 8.0. Protein content in each fraction was determined by spec-
trophotometry, and positive fractions were pooled, dialyzed, and
concentrated (Amicon, Inc., Beverly, MA). 2C8 hybridoma se-
creting PtC-specific IgM was provided by Dr. Leonore A.
Herzenberg (Stanford University, Stanford, CA), and 5E11 hy-
bridoma secreting PC-specific IgM was obtained from Dr. J.
Latham Claflin (University of Michigan Medical School, Ann Ar-
bor, MI [12, 16]). Anti-PtC and anti-PC IgM was isolated with
anti-IgM affinity column from ascites produced in recombination
activating gene (RAG)-2–deficient mice. Purity of IgM was ana-
lyzed by SDS-PAGE followed by Coomassie stain. Western blot
and ELISA were used to assess IgG contamination and degrada-
tion of IgM. All batches of purified IgM had no detectable degra-
dation and 
 
,
 
1% IgG contamination (data not shown). Endotoxin
levels in purified IgM was 
 
,
 
200 EU/ml as determined by Limu-
lus amebocyte lysate assay (Associates of Cape Cod, Woods Hole,
MA). In IgM reconstitution experiments, sIgM-deficient mice
were given 0.5 mg i.v. of polyclonal or monoclonal IgM in 0.5
ml PBS 4 h before CLP.
 
Assays.
 
Peritoneal lavage fluid was assayed for 
 
Escherichia coli
 
,
neutrophils, and the levels of endotoxin (LPS), TNF-
 
a
 
, and IL-6.
Serum was assayed for the levels of endotoxin, TNF-
 
a
 
, and IL-6.
 
E. coli
 
 colony-forming units (CFU) were determined by over-
night culture of serial dilutions of peritoneal lavage fluid on Luria
broth–agar plates at 37
 
8
 
C. Colonies of 
 
E. coli
 
 were identified in a
background of heterogeneous colonies by morphology and con-
firmed by culture on MacConkey II agar and by assay with the
Enteric Identification System (Organon Teknika, Durham, NC).
Neutrophils in the peritoneal lavage were analyzed by flow cyto-
metry using PE-conjugated anti-granulocyte antibody and FITC-
conjugated anti-CD19 antibody (PharMingen, San Diego, CA).
10
 
4
 
 live cells were collected for each sample, and neutrophils
were identified as GR
 
1
 
CD19
 
2
 
. TNF-
 
a
 
 and IL-6 were measured
by ELISA using commercial kits (Endogen, Inc., Cambridge,
MA; and Intergen Co., Purchase, NY). ELISA was performed
according to the manufacturer’s specification. Concentrations of
TNF-
 
a
 
 and IL-6 in individual samples were determined by com-
parison with a standard curve derived from the cytokine standard
supplied with the kits. Peritoneal and serum LPS were measured
using Limulus amebocyte lysate assay. LPS concentrations of indi-
vidual samples were calculated using a standard curve derived
from the LPS standard provided with the kit.
 
Results and Discussion
 
To examine the role of natural IgM in the immediate re-
sponse to microbial infection, we determined the suscepti-
bility of sIgM-deficient mice to acute septic peritonitis in-
duced by CLP that releases endogenous bacteria from the
cecum into the peritoneal cavity. 32 h after CLP, 70% of
sIgM-deficient mice died compared with 20% of the wild-
type mice (Fig. 1), indicating that the absence of natural
IgM rendered mutant mice much more susceptible to the
acute bacterial infection (
 
P
 
 , 
 
0.0001). The increased sus-
ceptibility of mutant mice to CLP was due to the absence
of sIgM, because reconstitution of mutant mice with a sin-
gle dose of 0.5 mg i.v. of total IgM isolated from normal
mouse serum 4 h before CLP restored their survival to the
same level as wild-type mice (Fig. 1). Similarly, sIgM-defi-
cient mice were also more sensitive to challenge by indi-
vidual species of pathogenic bacteria such as group B 
 
Strep-
tococcus
 
. The lethal dose to 50% (LD
 
50
 
) animals challenged
was 10-fold lower for sIgM-deficient mice than for wild-
type mice (our unpublished observations). sIgM-deficient
mice also showed increased incidence of spontaneous bac-
terial infection by opportunistic bacteria, including 
 
Pas-
teurella pneumotropica
 
, in specific pathogen–free facilities
Figure 1. Natural IgM confers
resistance to CLP. sIgM-deficient
(2/2) and wild-type (1/1)
mice at 6-8 wk of age were sub-
ject to CLP. IgM-reconstituted
sIgM-deficient mice (2/2 IgM)
were given as a single dose of 0.5
mg i.v. of total IgM affinity-
purified from normal mouse
serum 4 h before CLP. Mice
were monitored for survival
within the first 32 h. 
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(our unpublished observations). These data show that natu-
ral IgM is required for the protection against bacterial in-
fection.
Resistance to CLP is dependent on complement, mast
cells, and TNF-
 
a
 
 (17–20). The susceptibility of sIgM-defi-
cient mice to CLP is similar to mice deficient in comple-
ment component C3 or C4 or mast cells (17–19). The re-
quirement of natural IgM for resistance to CLP is probably
based on its ability to bind to bacteria and activate comple-
ment. To test this possibility, we determined the immedi-
ate response by assaying the levels of TNF-
 
a
 
, IL-6, and
LPS, neutrophil infiltration, and bacterial load in the peri-
toneal lavage 3 h after CLP. As in C3-deficient mice, the
levels of TNF-
 
a
 
 and IL-6 in mutant mice were approxi-
mately half those in wild-type mice (Table 1). Without
CLP, both sIgM-deficient and wild-type mice had very
few neutrophils in the peritoneum (
 
,
 
1%) and similar num-
bers of cells in the lavage after CLP (data not shown).
Again, as in C3-deficient mice, the percentage of neutro-
phils in the peritoneal lavage recovered from sIgM-defi-
cient mice was significantly reduced compared with that
from wild-type mice (55 vs. 82%; Table 1, and data not
shown). Furthermore, 10 times more 
 
E. coli
 
 were recov-
ered from the peritoneal lavage of sIgM-deficient mice
than from wild-type mice (Table 1). Associated with the
higher bacterial load, approximately twice the amount of
endotoxin (LPS) was detected in sIgM-deficient mice as in
wild-type mice. Reconstitution of sIgM-deficient mice
with total IgM restored the levels of TNF-
 
a
 
 and neutro-
phils and reduced 
 
E. coli
 
 load in the peritoneal lavage (Ta-
ble 1), consistent with the increased survival. These data
show that the effects resulting from the absence of sIgM on
the induction of TNF-
 
a
 
, neutrophil infiltration, and bacte-
rial load in the peritoneum are very similar to those seen in
the absence of C3, indicating that natural IgM functions
through the complement pathway.
IgM is the most potent complement activator among the
five classes of Igs. A single bound IgM molecule is sufficient
to activate complement to lyse a red blood cell (21). Bind-
ing of natural IgM to bacteria immediately after infection
likely results in the activation of complement through the
classical pathway. Since serum from sIgM-deficient mice
lysed antibody-opsonized red blood cells just as efficiently
as serum from wild-type mice in a hemolytic assay (data
not shown), the increased susceptibility of sIgM-deficient
mice to CLP is probably associated with the absence of
IgM-mediated complement activation. C3- or C4-defi-
cient mice appear to be even more sensitive to CLP than
sIgM-deficient mice as indicated by 100% mortality within
24 h (17). This may be because complement can also be ac-
tivated through the alternative and lectin pathways, and
complement is important in the efficient clearance of bac-
teria. In addition, sIgM-deficient mice have relatively nor-
mal levels of IgGs (13), some of which are probably natural
antibodies. Although the IgG proteins may contribute to
the survival of sIgM-deficient mice, they are clearly not
sufficient to compensate fully the absence of natural IgM.
Uncontrolled bacterial infection in the peritoneum leads
to a fatal systemic infection and inflammation. To deter-
mine the systemic inflammatory response to CLP in the ab-
sence of natural IgM, we collected serum from both sIgM-
deficient and wild-type mice at 1.5, 3, 6, and 12 h after
CLP and assayed for the levels of LPS, TNF-
 
a
 
, and IL-6.
We divided the sera into four groups based on the geno-
type of the mice and whether the mice died or survived at
32 h after CLP. As shown in Fig. 2, the levels of serum LPS
were similar to those of sham controls 3 h after CLP but
significantly higher at 6 and 12 h after CLP. Among the
four groups of mice, sIgM-deficient mice that died had a
significantly higher level of LPS by 6 h after CLP, consis-
tent with previous findings indicating that natural IgM is
involved in the clearance of LPS (22). Similarly, sIgM-defi-
cient mice that died had a significantly elevated level of
TNF-
 
a
 
 3 h after CLP (Fig. 2). Although the initial local
release of TNF-
 
a
 
 is beneficial to the containment of bacte-
rial infection, systemic release of TNF-
 
a
 
 is usually associ-
ated with wide-spread inflammation. The level of proin-
flammatory cytokine IL-6 was also elevated in the serum 6
 
Table 1.
 
Analyses of Peritoneal Lavage 3 h after CLP
 
1
 
/
 
12
 
/
 
22
 
/
 
2
 
 IgM
 
2
 
/
 
2
 
 PtC-IgM
 
2
 
/
 
2
 
 PC-IgM
TNF-
 
a
 
 (pg/ml) 1,507 892 2,068 1,643 304
IL-6 (pg/ml) 2,734 1,401 ND ND ND
Neutrophils (%) 81.7 54.8 83.5 69.6 22.1
 
E. coli
 
 (CFU) 34.9 
 
3
 
 10
 
3
 
350 
 
3
 
 10
 
3
 
2.3 
 
3
 
 10
 
3
 
62.5 
 
3
 
 10
 
3
 
510 
 
3
 
 10
 
3
 
LPS (EU/ml) 36.7 62.9 23.8 51.2 64.0
sIgM-deficient mice (
 
2
 
/
 
2
 
), wild-type mice (
 
1
 
/
 
1
 
), and IgM-reconstituted sIgM-deficient mice were subject to CLP. Peritoneal lavage was carried
out by injection of 3 ml i.p. of PBS with 2% FCS 3 h after CLP. IgM-reconstituted mice were given a single dose of 0.5 mg i.v. of purified poly-
clonal IgM from normal mouse serum or monoclonal IgM specific to PtC or PC 4 h before CLP. Peritoneal lavages of sIgM-deficient and wild-type
mice were each pooled from seven mice, and the levels of TNF-
 
a
 
, IL-6, and LPS, 
 
E. coli
 
 counts, and neutrophils were assayed (see Materials and
Methods). The levels of TNF-
 
a
 
 and LPS, 
 
E. coli
 
 counts, and neutrophils were assayed in peritoneal lavage from individual IgM-reconstituted mice.
The average of four mice is shown. Similar results were obtained in a separate experiment. 
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and 12 h after CLP in sIgM-deficient mice as well as in
wild-type mice that died (Fig. 2). IL-6 is a major cytokine
that induces the production of acute phase proteins, such as
C-reactive protein, that are thought to have similar func-
tions as natural antibodies (23–25). The similar levels of
serum IL-6 in both sIgM-deficient and wild-type mice sug-
gest that acute phase proteins were similarly elevated in
both types of mice. Thus, natural IgM appears to have
some unique functions in the immediate response against
bacterial infection that cannot be replaced by acute phase
proteins. In the absence of natural IgM, local bacterial infec-
tion leads to wide-spread inflammation and high mortality.
Reconstitution of sIgM-deficient mice with polyclonal
IgM from normal mouse serum restored their resistance to
CLP (Fig. 1). Therefore, it was of obvious interest to test
whether the resistance can be restored by reconstitution
with monoclonal IgM specific to PtC or PC. PtC is a com-
mon membrane component and anti-PtC is the most
widely expressed specificity by natural IgM (11, 12). PC is
chemically related to PtC and is found as a determinant of
the pneumococcal cell wall (26). Anti-PC IgM has been
shown to confer protection against certain types of 
 
Strepto-
coccus pneumoniae
 
 (27, 28). sIgM-deficient mice were given
a single dose of 0.5 mg i.v. of anti-PtC or PC IgM 4 h be-
fore CLP. 3 h after CLP, mice were killed and peritoneal
lavage was harvested to assay for the levels of TNF-
 
a
 
 and
LPS, neutrophil infiltration, and bacterial load. As in recon-
stitution with polyclonal IgM, reconstitution with anti-PtC
IgM resulted in elevated levels of TNF-
 
a
 
 and neutrophils
and a reduced 
 
E. coli
 
 load and LPS in the peritoneal lavage
(Table 1). In contrast, reconstitution with anti-PC IgM had
no obvious effect. The difference between the two mono-
clonal IgM preparations was probably due to their differ-
ences in specificity, because both were 
 
.
 
98% pure, had
minimal endotoxin contamination, and reconstituted to a
similar level as assayed by ELISA of serum taken 3 h after
CLP (data not shown). The resistance conferred by anti-
PtC IgM was clearly evident but it appeared not to be as
effective as polyclonal IgM, probably because polyclonal
IgM bind bacteria through many different antigenic deter-
minants. That anti-PtC IgM had a clear effect suggests that
it is involved in the immediate defense against bacterial in-
fection under physiological conditions.
Activation of complement is essential for the initial con-
tainment of systemic bacterial infection as demonstrated by
the susceptibility of complement-deficient humans, guinea
pigs, and mice to bacterial infection (17, 29–31). C5b–C9
membrane attack complex can lyse bacteria directly. C3a
and C5a peptides function as chemoattractants to recruit
leukocytes to the site of infection. Opsonization of bacteria
by C3b and iC3b promotes efficient phagocytosis by neu-
trophils. In addition, complement is required for the effi-
cient activation of mast cells to release TNF-
 
a
 
 for the initi-
ation of a local inflammatory response (17). However, the
optimal clearance of bacteria by complement requires the
presence of natural antibodies. Gram-positive bacteria are
generally resistant to complement-mediated lysis because
the thick peptidoglycan layer in their cell wall prevents in-
sertion of the membrane-attack complex (32). Although
gram-negative bacteria are effectively lysed by comple-
ment, these bacteria contain LPS in their cell walls which
when released in substantial amount can be fatal within
hours (33, 34). Furthermore, sialic acids of the pneumo-
coccal capsular polysaccharides can inhibit the activation of
the alternative complement pathway (35). The capsular
polysaccharides also inhibit phagocytosis by macrophages
and neutrophils (36). Effective responses to bacterial infec-
tion require antibodies to opsonize bacteria for efficient
phagocytosis and to neutralize the released endotoxin (22).
What is the source of antibodies before the onset of a specific
humoral response to a particular infectious agent? Natural
IgM is ideally suited for these purposes because of its poly-
reactivities and the exquisite ability to activate complement,
and because normally it is already present. The susceptibility
of sIgM-deficient mice to CLP and restoration of resistance
by reconstitution with polyclonal IgM and to a lesser extent
by anti-PtC IgM clearly demonstrate a critical role of natural
IgM in the immediate defense against bacterial infection.
 
We thank Drs. Leonore A. Herzenberg and J. Latham Claflin for anti-PtC and PC hybridomas, respectively;
Drs. Yong Wang and Jay Austen for helping with hemolytic assay; Dr. Herman Eisen for critical reading of
the manuscript; and members of the laboratory for help and discussion.
Figure 2. Comparison of the
levels of LPS, TNF-a, and IL-6
in the serum of sIgM-deficient
and wild-type mice at different
time points after CLP. Sera were
collected at 1.5, 3, 6, and 12 h
after CLP and divided into four
groups based on the genotype of
the mice and whether the mice
died or survived at 32 h after
CLP. Sham control was operated
on without ligation and puncture.
Concentrations of LPS, TNF-a,
and IL-6 were determined by
ELISA. Error bars indicate SD.
For TNF-a assay, the numbers of
mice used in each category are as
follows:  2/2 dead, 12; 2/2
survived, 10; 1/1 dead, 10; and
1/1 survived, 16. Eight mice
were used in each category for
IL-6 assay. Six mice were used in
each category for LPS assay.
Numbers of sham controls for
TNF-a, IL-6, and LPS were 2, 1,
and 1, respectively. 
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